𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in mice

✍ Scribed by Howard Sands; Scott E. Loveless

Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
406 KB
Volume
11
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Biodistribution of iodine-125 labeled mo
Biodistribution of iodine-125 labeled monoclonal antibody/Interleukin-2 immunoconjugate in athymic mice bearing human tumor xenografts
✍ Kayoko Nakamura; Atsushi Kubo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Background: Some vasoactive drugs have been studied in the hope of altering the vascular permeability and/or blood of tumors to enhance monoclonal antibody (moab) uptake. the pretreatment of interleukin-2 (il-2), one of the vasoactive reagents, produced a generalized vascular permeability, but i

Biodistribution, pharmacokinetics and im
Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer
✍ Hidde J. Haisma; Karan R. Moseley; Anne I. Battaile; Thomas C. Griffiths; Vincen πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 394 KB

Fifteen patients with or suspected of having ovarian carcinoma were injected intravenously (i.v.) or intraperitoneally (i.p+) with t3tl-labelled OC 125 F(ab')z. Radioimmunoscintigraphy after i.v. injection revealed 50% of the tumor sites. After i.p. injection all tumor sites were visualized, except

Preparation and quality control of 211At
Preparation and quality control of 211At-labelled and 125I-labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenografts
✍ Roy H. Larsen; Per Hoff; Jorolf Alstad; Øyvind S. Bruland πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 439 KB

## Abstract Two anti‐osteosarcoma monoclonal antibodies (TP‐3 IgG and TP‐1 F(abβ€²)~2~) were labelled with the α‐particle emitting radionuclide ^211^At and, for comparison of stability, with ^125^I using the N‐succinimidyl‐3‐(trimethylstannyl)benzoate intermediate. The quality of the final preparatio

Combination tumor-immunotherapy with rec
Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice
✍ Takashi Nishimura; So Ohta; Naoko Sato; Yuji Togashi; Makiko Goto; Yoshiyuki Has πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 656 KB

Recombinant human tumor necrosis factor (r-TNF) inhibits growth of various mouse tumor cell lines both in vitro and in vivo. Treatment of established tumor nodules with intratumoral (i.t.) injection of r-TNF caused hemorrhagic necrosis of tumor and temporary disappearance of tumor mass. However, a s